Understanding Hypoactive Sexual Desire Disorder (HSDD) in Women: Etiology, Diagnosis, and Treatment
- PMID: 38161863
- PMCID: PMC10757759
- DOI: 10.7759/cureus.49690
Understanding Hypoactive Sexual Desire Disorder (HSDD) in Women: Etiology, Diagnosis, and Treatment
Abstract
Hypoactive Sexual Desire Disorder (HSDD) is a complex and multifaceted condition that significantly impacts the sexual well-being and overall quality of life of women. This comprehensive review aims to provide a holistic understanding of HSDD by exploring its etiology, diagnostic criteria, treatment approaches, and broader societal implications. The review delves into the intricate interplay of biological factors, including hormonal changes and neurotransmitter imbalances, that contribute to HSDD. Psychological factors, such as relationship issues, body image, and stress, are examined with sociocultural factors like societal norms, cultural influences, and media portrayals of sexuality. Diagnostic criteria and assessment methods, including The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria, and self-report questionnaires, are explored to facilitate accurate identification of HSDD and differentiation from other sexual disorders. The impact of HSDD on women's quality of life and relationships is examined, highlighting the emotional strain and interpersonal challenges associated with the disorder. Societal and personal consequences of untreated HSDD underscore the need for increased awareness and support. Treatment approaches encompass non-pharmacological interventions such as cognitive-behavioral therapy, sex therapy, and couples therapy and pharmacological interventions like hormone therapy and selective serotonin reuptake inhibitors. Novel treatments like bremelanotide, flibanserin, and integrative strategies combining psychotherapy and lifestyle changes are discussed. Challenges and controversies surrounding HSDD, including the lack of consensus on diagnostic criteria, debates about the medicalization of sexuality, ethical concerns regarding pharmaceutical interventions, and cultural considerations, are addressed. Future directions in research, including advances in neurobiological understanding, personalized medicine, long-term treatment studies, and destigmatization initiatives, offer promising pathways for enhancing the management of HSDD.
Keywords: etiology and diagnosis; hypoactive sexual desire disorder; personalized interventions; sociocultural impact; treatment approaches; women's sexual health.
Copyright © 2023, Ronghe et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment.J Womens Health (Larchmt). 2020 Aug;29(8):1101-1112. doi: 10.1089/jwh.2019.7865. Epub 2020 May 27. J Womens Health (Larchmt). 2020. PMID: 32460605
-
Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment.Sex Med Rev. 2016 Apr;4(2):103-120. doi: 10.1016/j.sxmr.2015.11.009. Epub 2016 Feb 6. Sex Med Rev. 2016. PMID: 27872021 Review.
-
Pharmacotherapy of Hypoactive Sexual Desire Disorder in Premenopausal Women.Ann Pharmacother. 2024 May 20:10600280241253273. doi: 10.1177/10600280241253273. Online ahead of print. Ann Pharmacother. 2024. PMID: 38767282 Review.
-
Evaluation and Management of Hypoactive Sexual Desire Disorder.Sex Med. 2018 Jun;6(2):59-74. doi: 10.1016/j.esxm.2018.01.004. Epub 2018 Mar 6. Sex Med. 2018. PMID: 29523488 Free PMC article. Review.
-
Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options.J Sex Med. 2017 Dec;14(12):1575-1584. doi: 10.1016/j.jsxm.2017.10.068. J Sex Med. 2017. PMID: 29198512 Review.
References
-
- The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Brotto LA. Arch Sex Behav. 2010;39:221–239. - PubMed
-
- Female hypoactive sexual desire disorder: epidemiology, diagnosis and treatment. Warnock JJ. CNS Drugs. 2002;16:745–753. - PubMed
-
- Dopamine and serotonin: influences on male sexual behavior. Hull EM, Muschamp JW, Sato S. Physiol Behav. 2004;83:291–307. - PubMed
Publication types
LinkOut - more resources
Full Text Sources